Recall of Roche Cobas 4800

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Roche Diagnostics GmbH.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    21072
  • Event Initiated Date
    2017-02-02
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Roche Diagnostics (NZ) Ltd, 15 Rakino Way, Mt Wellington, AUCKLAND 1644
  • Reason
    In extremely rare circumstances, the algorithm for the cobas® hiv-1 and hbv tests for use on the cobas® 4800 system may inappropriately call an extraordinarily high viral load sample as negative (i.E., false negative result). this situation occurs when the positive pcr growth curve for the target has a ct value below the ct minimum for the test, resulting in the kinetic algorithm calling the curve negative instead of invalid.
  • Action
    Manufacturer to issue advice regarding use

Device

  • Model / Serial
    Model: , Affected: cobas HBV Test for use on the cobas 4800 system (06979564190)
  • Manufacturer

Manufacturer